JOHN MOSES: Open Payments
NPI 1447737481 · AIEA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,058 in 60 payments from 11 companies in 2025. Trend: 2023 $1,317 · 2024 $12,740 · 2025 $5,058
Speaker / faculty: $2,160Food & beverage: $1,704Consulting: $675Travel & lodging: $519
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 28 | $4,205 |
| Axsome Therapeutics, Inc. | 5 | $194 |
| ABBVIE INC. | 10 | $179 |
| Teva Pharmaceuticals USA, Inc. | 2 | $156 |
| Lundbeck LLC | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Indivior Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
Products named: VIVITROL, ARISTADA, LYBALVI, Auvelity, UZEDY, VRAYLAR, REXULTI, INVEGA SUSTENNA.
Industry payments across HI — which companies pay providers there.
